Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Research finds higher rates of cancer in world's ‘better’ countries

The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.

11 Oct 2017

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).

28 Sep 2017

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Two papers involving ovarian cancer research at the University of Notre Dame's Harper Cancer Research Institute, one featuring new research and the other a review article, were published as cover stories in their respective journals.

27 Sep 2017

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

Researchers from the People's Friendship University of Russia have studied the mechanism of drug resistance for ovarian and breast cancer cells.

22 Sep 2017

MIT engineers design more effective synthetic mRNA delivery system

By delivering strands of genetic material known as messenger RNA into cells, researchers can induce the cells to produce any protein encoded by the mRNA. This technique holds great potential for administering vaccines or treating diseases such as cancer, but achieving efficient delivery of mRNA has proven challenging.

21 Sep 2017

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Ovarian cancer is the 9th most common cancer in women and although it only accounts for approximately 3 percent of cancers in women, it is responsible for the most deaths of any cancer involving the female reproductive tract.

20 Sep 2017

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

For many years, oncologists have known that cancers can secrete complex molecules into the blood and that levels of these molecules can be easily measured. These so-called 'tumor markers' are traditionally associated with a single dominant cancer type, for example Prostate Specific Antigen (PSA) linked to prostate cancer, Carcinoembryonic antigen (CEA) to colorectal cancer, CA125 to ovarian cancer, CA19.9 to pancreatic cancer and CA27.29 to breast cancer.

6 Sep 2017

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for Prostate Cancer) suggests that screening reduced prostate cancer deaths, the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found that regular screening does not reduce the cancer death rates in prostate cancer. Researchers thus looked at the actual picture as to which of these – ERSPC or PLCO are correct.

5 Sep 2017

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

A recent survey by a gynaecological cancer charity has shown that nearly half of the men could not identify a woman’s vagina correctly on a diagram.

31 Aug 2017

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

The Southeast's first comprehensive cancer treatment program at the University of Alabama at Birmingham takes patient care to the next level by improving the lives of women affected by or at risk for ovarian cancer.

31 Aug 2017

Coffee consumption connected to a longer life

At the European Society of Cardiology, ESC Congress 1 last weekend, Spanish researchers working as part of the long term project Seguimiento Universidad de Navarra (SUN) Project, presented their new study that suggests coffee intake might be tied to a longer life. The study included around 20,000 Spanish participants.

28 Aug 2017

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

A team of Cleveland Clinic researchers have discovered a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much needed new therapies for women with limited options.

24 Aug 2017

New clinical trial to test cancer drug in patients with advanced solid tumors

A clinical trial to test a new cancer drug in patients with advanced solid tumors, launches in four centers across the UK today (Wednesday), through Cancer Research UK's Center for Drug Development.

23 Aug 2017

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes

A new study conducted by the UCLA Fielding School of Public Health, states that among nearly 4 million women in the United States who possess a medical history of ovarian cancer or breast cancer, 1.5 million have an increased risk of bearing some kinds of genetic mutations, which might increase the probability of causing additional cancers in the future.

21 Aug 2017

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Of the nearly 4 million women in the United States who have had either breast cancer or ovarian cancer, at least 1.5 million have a high risk of carrying certain types of genetic mutations that could increase their risk for additional cancers in the future.

21 Aug 2017

Novel blood test identifies tumor-derived DNA in early-stage cancer patients

In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.

17 Aug 2017

Liquid biopsies show potential use for cancer screening

A new study has shown the potential of analyzing cell-free DNA (cfDNA) present in patients’ blood for cancer markers in early cancer detection. This technique was used in some instances for patients who already were diagnosed with a cancer as reported by some studies.

16 Aug 2017

Mount Sinai experts offer tips on knowing risks and detecting symptoms of ovarian cancer

Ovarian cancer is the fourth leading cause of death in American women and according to the National Cancer Institute, approximately 22,000 women will be diagnosed with the disease and 14,000 will die from it.

11 Aug 2017

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Research finds higher rates of cancer in world's ‘better’ countries

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Researchers discover mechanism of drug resistance for ovarian and breast cancer cells

MIT engineers design more effective synthetic mRNA delivery system

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Blood tumor markers could be useful in monitoring therapeutic outcomes for lung cancer patients

Prostate cancer screening reduces cancer deaths finds new analysis

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

50% of men struggle to identify a woman’s vagina correctly on a diagram: Survey

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Coffee consumption connected to a longer life

Study may lead to new therapy options for treatment resistant, relapsed endometrial cancer

New clinical trial to test cancer drug in patients with advanced solid tumors

Women with a medical history of breast or ovarian cancer often fail to test for inherited genetic changes

Study: More than 80% of women at risk for breast, ovarian cancer have not taken simple genetic test

Novel blood test identifies tumor-derived DNA in early-stage cancer patients

Liquid biopsies show potential use for cancer screening

Mount Sinai experts offer tips on knowing risks and detecting symptoms of ovarian cancer

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in